Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
6.95
-0.47 (-6.33%)
Oct 16, 2025, 4:00 PM EDT - Market closed

Biodesix Statistics

Total Valuation

Biodesix has a market cap or net worth of $54.21 million. The enterprise value is $106.95 million.

Market Cap54.21M
Enterprise Value 106.95M

Important Dates

The next estimated earnings date is Friday, October 31, 2025, before market open.

Earnings Date Oct 31, 2025
Ex-Dividend Date n/a

Share Statistics

Biodesix has 7.80 million shares outstanding. The number of shares has increased by 48.04% in one year.

Current Share Class 7.80M
Shares Outstanding 7.80M
Shares Change (YoY) +48.04%
Shares Change (QoQ) +0.07%
Owned by Insiders (%) 52.01%
Owned by Institutions (%) 17.71%
Float 3.23M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.67
Forward PS 0.56
PB Ratio 44.76
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 1.40
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.14, with a Debt / Equity ratio of 64.56.

Current Ratio 2.14
Quick Ratio 1.86
Debt / Equity 64.56
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -4.60

Financial Efficiency

Return on equity (ROE) is -219.68% and return on invested capital (ROIC) is -24.48%.

Return on Equity (ROE) -219.68%
Return on Assets (ROA) -20.81%
Return on Invested Capital (ROIC) -24.48%
Return on Capital Employed (ROCE) -46.70%
Revenue Per Employee $280,425
Profits Per Employee -$150,469
Employee Count273
Asset Turnover 0.75
Inventory Turnover 11.61

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -78.55% in the last 52 weeks. The beta is 0.98, so Biodesix's price volatility has been similar to the market average.

Beta (5Y) 0.98
52-Week Price Change -78.55%
50-Day Moving Average 8.06
200-Day Moving Average 11.47
Relative Strength Index (RSI) 41.94
Average Volume (20 Days) 60,533

Short Selling Information

The latest short interest is 161,558, so 2.07% of the outstanding shares have been sold short.

Short Interest 161,558
Short Previous Month 297,541
Short % of Shares Out 2.07%
Short % of Float 5.00%
Short Ratio (days to cover) 0.50

Income Statement

In the last 12 months, Biodesix had revenue of $76.56 million and -$41.08 million in losses. Loss per share was -$5.60.

Revenue76.56M
Gross Profit 60.30M
Operating Income -33.89M
Pretax Income -41.08M
Net Income -41.08M
EBITDA -28.08M
EBIT -33.89M
Loss Per Share -$5.60
Full Income Statement

Balance Sheet

The company has $20.73 million in cash and $73.47 million in debt, giving a net cash position of -$52.74 million or -$6.76 per share.

Cash & Cash Equivalents 20.73M
Total Debt 73.47M
Net Cash -52.74M
Net Cash Per Share -$6.76
Equity (Book Value) 1.14M
Book Value Per Share 0.16
Working Capital 17.29M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$29.94 million and capital expenditures -$1.20 million, giving a free cash flow of -$31.13 million.

Operating Cash Flow -29.94M
Capital Expenditures -1.20M
Free Cash Flow -31.13M
FCF Per Share -$3.99
Full Cash Flow Statement

Margins

Gross margin is 78.77%, with operating and profit margins of -44.27% and -53.66%.

Gross Margin 78.77%
Operating Margin -44.27%
Pretax Margin -53.66%
Profit Margin -53.66%
EBITDA Margin -36.67%
EBIT Margin -44.27%
FCF Margin n/a

Dividends & Yields

Biodesix does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -48.04%
Shareholder Yield -48.04%
Earnings Yield -75.78%
FCF Yield -57.43%

Analyst Forecast

The average price target for Biodesix is $32.50, which is 367.63% higher than the current price. The consensus rating is "Strong Buy".

Price Target $32.50
Price Target Difference 367.63%
Analyst Consensus Strong Buy
Analyst Count 5
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on September 15, 2025. It was a reverse split with a ratio of 1:20.

Last Split Date Sep 15, 2025
Split Type Reverse
Split Ratio 1:20

Scores

Biodesix has an Altman Z-Score of -6.75 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -6.75
Piotroski F-Score 3